Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...

Angina IV: Management

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

Coronary Artery Disease V: Interprofessional Care

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The watchmaker's eye: Exposure keratopathy with secondary limbal stem cell deficiency due to the use of a loupe.

Journal francais d'ophtalmologie·2025

Same author

Simultaneous intraocular and orbital involvement of NK/T-cell lymphoma.

Journal francais d'ophtalmologie·2021

Same author

[Lipemia retinalis: contribution of ultra-widefield imaging and spectral domain OCT].

Journal francais d'ophtalmologie·2019

Same author

[Vitreous hemorrhage, persistent fetal vasculature and Incontinentia Pigmenti].

Journal francais d'ophtalmologie·2017

Same author

[Corneal complications of a case of vernal keratoconjonctivitis].

Journal francais d'ophtalmologie·2017

Same author

[Uncomplicated massive central retinal artery embolism].

Journal francais d'ophtalmologie·2017

Search research articles

Related Experiment Video

Updated: Jul 2, 2026

Isolation, Culture, and Genetic Engineering of Mammalian Primary Pigment Epithelial Cells for Non-Viral Gene Therapy

Isolation, Culture, and Genetic Engineering of Mammalian Primary Pigment Epithelial Cells for Non-Viral Gene Therapy

Published on: February 26, 2021

[Non-Pharmacological Interventional Perspectives in AMD].

G Thumann¹, P Walter

¹IZKF Biomat, RWTH Aachen. Gthumann@ukaachen.de

Klinische Monatsblatter Fur Augenheilkunde

|August 21, 2008

Summary

This summary is machine-generated.

Current treatments for age-related macular degeneration (AMD) have limited success. This research explores novel surgical strategies, including cell transplantation on biodegradable scaffolds, to reconstruct the retina-choroid complex for improved vision recovery in AMD patients.

More Related Videos

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Related Experiment Videos

Last Updated: Jul 2, 2026

Isolation, Culture, and Genetic Engineering of Mammalian Primary Pigment Epithelial Cells for Non-Viral Gene Therapy

Isolation, Culture, and Genetic Engineering of Mammalian Primary Pigment Epithelial Cells for Non-Viral Gene Therapy

Published on: February 26, 2021

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Area of Science:

Ophthalmology
Regenerative Medicine
Biomaterials Science

Context:

Age-related macular degeneration (AMD) is a leading cause of vision loss.
Current treatments like anti-vascularization inhibitors show limited efficacy (approx. 30% vision recovery).
Patient selection criteria for anti-vascularization treatments remain unclear, necessitating alternative approaches.

Purpose:

To investigate the limitations of current AMD treatments.
To propose a novel surgical approach for AMD using cell transplantation on biodegradable scaffolds.
To reconstruct the damaged retina-choroid complex for potential vision restoration.

Summary:

Surgical interventions for AMD, including cell transplantation and macular rotation, have shown limited long-term success.
Damage to the retinal pigment epithelial cells and Bruch's membrane in AMD requires reconstruction.
A promising approach involves transplanting pigment cells on a natural, biodegradable extracellular matrix scaffold.

Impact:

This approach aims to restore the retinal pigment epithelial cell layer and Bruch's membrane.
Engineered cells on scaffolds can deliver therapeutic factors to aid retinal repair.
Successful reconstruction could lead to significant vision recovery in AMD patients unresponsive to current therapies.